Cti Biopharma Corp

CIK 891293 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cti Biopharma Corp.

Recent SEC filings

FiledFormAccession number
Jul 6, 202315-12G0001193125-23-182785
Jun 29, 2023EFFECT9999999995-23-001879
Jun 29, 2023EFFECT9999999995-23-001935
Jun 29, 2023EFFECT9999999995-23-001900
Jun 29, 2023EFFECT9999999995-23-001936
Jun 29, 2023EFFECT9999999995-23-001883
Jun 29, 2023EFFECT9999999995-23-001881
Jun 29, 2023EFFECT9999999995-23-001893
Jun 29, 2023EFFECT9999999995-23-001904
Jun 29, 2023EFFECT9999999995-23-001887
Jun 29, 2023EFFECT9999999995-23-001934
Jun 29, 2023EFFECT9999999995-23-001882
Jun 29, 2023EFFECT9999999995-23-001895
Jun 29, 2023EFFECT9999999995-23-001889
Jun 29, 2023EFFECT9999999995-23-001885
Jun 29, 2023EFFECT9999999995-23-001880
Jun 29, 2023EFFECT9999999995-23-001891
Jun 29, 2023EFFECT9999999995-23-001933
Jun 29, 2023EFFECT9999999995-23-001909
Jun 29, 2023EFFECT9999999995-23-001894
Jun 29, 2023EFFECT9999999995-23-001901
Jun 29, 2023EFFECT9999999995-23-001932
Jun 29, 2023EFFECT9999999995-23-001914
Jun 29, 2023EFFECT9999999995-23-001888
Jun 29, 2023EFFECT9999999995-23-001930